Monopar Therapeutics
MNPR
MNPR
35 hedge funds and large institutions have $109M invested in Monopar Therapeutics in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.
Holders
35
Holders Change
+17
Holders Change %
+94.44%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
6
Reduced
5
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Janus Henderson Group
London,
United Kingdom
|
$45.6M |
| 2 |
AAA
2
Affinity Asset Advisors
New York
|
$2.26M |
| 3 |
3
Millennium Management
New York
|
$2.2M |
| 4 |
4
Marshall Wace
London,
United Kingdom
|
$946K |
| 5 |
5
Goldman Sachs
New York
|
$673K |
Top Sellers
| 1 |
ACM
1
ADAR1 Capital Management
Austin,
Texas
|
$3.67M |
| 2 |
2
Morgan Stanley
New York
|
$51.8K |
| 3 |
3
JPMorgan Chase & Co
New York
|
$3.64K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$2.01M |
| 5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$11K |
